ArticleFrontiers in pharmacology2025

Novel human single-domain antibodies exert potent anti-tumor activity by targeting EGF-like repeat epitope of EpCAM.

Xiaofeng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.